Brian Hurley (Novartis)
Events
Title: The discovery and development of small molecule splicing modulators for the treatment of Spinal Muscular Atrophy (SMA)
Novartis Symposium
Content tagged with Novartis Symposium
Not finding what you're looking for? Try using Advanced Search.
Not finding what you're looking for? Try using Advanced Search.
Novartis Symposium
Events
Professor Eranthie Weerapana, Boston College: "Chemical-proteomic strategies to investigate cysteine reactivity." Dr. Richard Robinson, Novartis Institutes for BioMedical Research: "Tipping the Scales: Leveraging Synthetic Technologies in Pharmaceutical R...
Novartis Symposium
Events
The Novartis Symposium. Professor Timothy Newhouse, Yale University. TBA. Research Scientist, Novartis, TBA.
Novartis Symposium - Postponed to May 1
Events
Professor Anna Mapp, University of Michigan. TBA. Dr. David Sandham, Novartis. "Discovery of novel DP2 receptor antagonists for treatment of asthma: Case history of Fevipiprant."
Novartis Symposium
Events
Dr. Gisele Nishiguchi, Novartis, Inc. " Discovery of the clinical candidate PIM447 for the treatment of cancer - A medicinal chemistry story." Professor Nathanael Gray, Dana Farber Cancer Institute. "Developing New Strategies for Selective Targeting of...
Novartis Chemical Sciences Lectureship
Events
Professor Herbert Waldmann, MPI-Dortmund. Biology Oriented Synthesis. Dr. Chris Brain, Novartis Institute for Biomedical Research. The discovery of LEE011, a selective inhibitor of CDK4/6 for the treatment of cancer.
Novartis Symposium
Events
Location: Pfizer Lecture Hall, 12 Oxford St., Cambridge, 02138 ( map) Professor Elizabeth Jarvo, University of California, Irvine. "Mechanism-Based Design and Development of Nickel-Catalyzed Reactions Stereospecific Cross-Coupling Reactions" TBA, Novartis...